Enhancing national competitiveness through partnerships & investments in R&D

Panel discussion on Enhancing national competitiveness through partnerships & investments in R&D at 1st SfEE Summit

√ Konstantinos Panagoulias, Vice President, VIANEX, S.A.; Alternate President, SFEE, Greece
√ Dimitris Demos, CEO & Deputy Managing Director, Demo SA Pharmaceuticals; Vice President PEF, Greece
√ Spyros Filiotis, Vice President & General Manager, Pharmaserve-Lilly, Greece
√ Nikos Vettas, General Director, Foundation for Economic & Industrial Research IOBE; Professor, Athens University of Economics & Business, Greece
√ Angelos Benos, Partner, Pharma Industry Lead, PwC, Greece

√ Moderator: Katerina Douka, Journalist, ERT


The Hellenic Association of Pharmaceutical Companies (SFEE) organized the 1st SfEE Summit, which took place on June 18th, 2024, at the Megaron International Conference Center in Athens.

In a dynamically evolving environment, the challenges facing the Greek healthcare and pharma sector make the redefinition of the role and value of our sector to the healthcare system, society, and the economy imperative.

The 1st SfEE Summit, under the main theme “Redefining Value," focused on the value of the pharmaceutical industry to the Greek economy, the value and role of pharmaceutical innovation, the latest trends in the healthcare and pharma environment, as well as the challenges and opportunities of the Greek pharma sector.

https://sfeesummit.gr/